Global Albumin Market, By Type (Human Serum Albumin, Bovine Serum Albumin, Recombinant Albumin), Application (Therapeutics, Vaccine Ingredient, Drug Delivery, Culture Media, Vaccine Ingredient, Others), End User (Hospitals, Clinics, Pharmaceutical and Biotechnology, Research Institutes), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) Industry Trends and Forecast to 2028

The global albumin market was worth USD 0.81 billion in 2021 and is poised to accumulate a valuation of USD 1.7 billion by 2030, registering a CAGR of 6.3% over the forecast duration of 2022-2030.

The global albumin market was worth USD 0.81 billion in 2021 and is poised to accumulate a valuation of USD 1.7 billion by 2030, registering a CAGR of 6.3% over the forecast duration of 2022-2030.

The Bovine Serum Albumin Market growth at a CAGR of 16.1% & projected USD 18.42 billion by 2029. It is divided on the basis of product and application.